Co Agonists Of The Glp 1 And Amylin Receptors

Abstract: The invention relates to a compound comprising a GLP-1 receptor agonist and an amylin receptor agonist. The invention also relates to a pharmaceutical formulation, suitable for but not limited to oral administration, which comprises such a compound. The compound and pharmaceutical formulation comprising it may be used for the medical treatment of subjects with overweight, obesity and associated co-morbidities.

Patent Information

Application #

Filing Date

13 July 2023

Publication Number

05/2024

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

Parent Application

Applicants

NOVO NORDISK A/S

Novo Allé 2880 Bagsværd

Inventors

1. KRUSE, Thomas

Novo Allé 2880 Bagsværd

2. KODAL, Anne, Louise, Bank

Novo Allé 2880 Bagsværd

3. MADSEN, Johnny

Novo Allé 2880 Bagsværd

4. ØSTERGAARD, Søren

Novo Allé 2880 Bagsværd

5. HOGENDORF, Wouter, Frederik, Johan

Novo Allé 2880 Bagsværd

6. TORNØE, Christian, Wenzel

Novo Allé 2880 Bagsværd

7. MADSEN, Alice, Ravn

Novo Allé 2880 Bagsværd

Specification

Documents

Application Documents

#	Name	Date
1	202347047263-STATEMENT OF UNDERTAKING (FORM 3) [13-07-2023(online)].pdf	2023-07-13
2	202347047263-Sequence Listing in txt [13-07-2023(online)].txt	2023-07-13
3	202347047263-Sequence Listing in PDF [13-07-2023(online)].pdf	2023-07-13
4	202347047263-PRIORITY DOCUMENTS [13-07-2023(online)].pdf	2023-07-13
5	202347047263-POWER OF AUTHORITY [13-07-2023(online)].pdf	2023-07-13
6	202347047263-FORM 1 [13-07-2023(online)].pdf	2023-07-13
7	202347047263-DRAWINGS [13-07-2023(online)].pdf	2023-07-13
8	202347047263-DECLARATION OF INVENTORSHIP (FORM 5) [13-07-2023(online)].pdf	2023-07-13
9	202347047263-COMPLETE SPECIFICATION [13-07-2023(online)].pdf	2023-07-13
10	202347047263-FORM 18 [19-07-2023(online)].pdf	2023-07-19
11	202347047263-FORM-26 [06-09-2023(online)].pdf	2023-09-06
12	202347047263-FORM-26 [25-10-2023(online)].pdf	2023-10-25
13	202347047263-Proof of Right [22-12-2023(online)].pdf	2023-12-22
14	202347047263-FORM 3 [11-01-2024(online)].pdf	2024-01-11